MANKIND:NSE
Mankind Pharma Ltd
₹2,626.60
arrow_downward
-0.51%(-13.40) 1D
Nov 16, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MANKIND...
Open
₹2,625.60
High
₹2,694.00
Low
₹2,612.20
Mkt. cap
1.08T
Avg. vol.
720.90K
Volume
427.08K
P/E ratio
48.40
52-wk high
₹2,705.00
52-wk low
₹1,909.70
EPS
₹54.27
No. of employees
20K
Open
₹2,625.60
High
₹2,694.00
Low
₹2,612.20
Mkt. cap
1.08T
Avg. vol.
720.90K
Volume
427.08K
P/E ratio
48.40
52-wk high
₹2,705.00
52-wk low
₹1,909.70
EPS
₹54.27
No. of employees
20K
News stories
From web sources and news partners
Nieuws.nl
·
11 hours ago
AEX-index begint voorzichtig aan belangrijke week voor AI-sector
Investor's Business Daily
·
23 minutes ago
Tyson, Starbucks Lead The S&P 500, Nasdaq 100 As Investors Play Defense
WSJ
·
16 minutes ago
Stock Market Today: Nasdaq Slides 1.5% as Nvidia Drama Continues to Unfold — Live Updates
The Motley Fool
·
1 hour ago
McDonald's Is Underperforming the S&P 500 and Nasdaq-100. Could January Mark a Turning Point?
Profile
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
About Mankind Pharma Ltd
CEORajeev Juneja | Sheetal Arora
Employees20.5K
Founded1991
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitemankindpharma.com